RESEARCH

CLINICAL EFFECTIVENESS OF THREE MODELS FOR COMPREHENSIVE CARDIOVASCULAR RISK REDUCTION IN LOWER RISK PATIENTS WITH CORONARY ARTERY DISEASE.

(Presented at the American Heart Association Research Symposium, Dallas, Texas, May 2000)

Neil F. Gordon, Center for Heart Disease Prevention, St. Joseph's/Candler Health System, Savannah, GA

METHODS

·      157 male and female volunteers with documented CAD

·      All patients at lower-risk for recurrent cardiac events

·      Testing conducted at baseline (pre-randomization) and
   repeated after 12 weeks and 1 year of study participation:

-        Health history questionnaire, including SF-36

-        Fasting serum lipids and lipoproteins and glucose

-        Weight, BMI, waist circumference, hip circumference

-        Resting BP

-        Maximal graded exercise test with measurement of
      maximal oxygen uptake

·      Patients randomly assigned after baseline testing to one of
   three groups as follows:

Group 1 = 12 weeks of participation in a traditional phase 2 cardiac rehabilitation program

Group 2 = One year of participation in a physician-supervised, nurse-case managed comprehensive cardiovascular risk reduction program

Group 3 = One year of participation in a community based comprehensive cardiovascular risk reduction program administered by non-physician health care professionals guided by a computerized participant management and tracking system

NEXT PAGE            PREVIOUS PAGE